Riskpilot← Back to searchSign inGet full accessDr Wilberg AB
ABActiveOrg 5594235045Pipersgatan 5 AMedical specialists activities · NACE 8622Est. 20231 employees
Revenue 2024
SEK 122K
-28% vs 2023
EBITDA margin
—
Equity ratio
64.5%
Financial strength
Net profit 2024
SEK -2K
-103% vs 2023
| Revenue | SEK 122K | -28% |
| EBITDA | — | — |
| Net profit | SEK -2K | -103% |
| Total assets | SEK 138K | -16% |
| Equity | SEK 89K | -2% |
| Employees | 1 | — |
Legal name
Dr Wilberg AB
Org number
5594235045
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 februari 2023
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanterna
Company purpose
Läkarkonsultverksamhet. Undertecknad samt styrelseledamoten i företaget är specilistläkare. Bolaget skall bedriva personaluthyrning, konsultation, behandling, undervisning och forskning inom hälso- och sjukvård, äga och förvalta fast och lös egendom även som idka därmed förenlig verksamhet. Bolaget kan investera sin kassa i värdepapper och fonder.
Address
Pipersgatan 5 A
Email
andriwo@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 170 | 122 |
| Staff expenses | — | — |
| EBITDA | 83 | — |
| Depreciation & amort. | −0 | −0 |
| EBIT | 83 | 0 |
| Net financials | 1 | 3 |
| Profit before tax | 84 | 2 |
| Tax | −18 | −4 |
| Net profit | 66 | −2 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 164 | 138 |
| Equity | 91 | 89 |
| Long-term debt | 0 | 0 |
| Short-term debt | 73 | 49 |
| Total debt | 73 | 49 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20232024
Equity ratio
64.5%
This company
38.2%
Market median
+69% vs market
20232024
Return on equity
-2.2%
This company
18.4%
Market median
-112% vs market
20232024
Net profit margin
-1.6%
This company
8.1%
Market median
-120% vs market
20232024
Asset turnover
0.88×
This company
1.12×
Market median
+21% vs market
20232024
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LV Chief Executive Officer | Chief Executive Officer | 2025 |
RG Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Deputy Board Member | 2023 | |
| Former (1) | ||
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Wilberg AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leifur Vilberg Orrason | Chief Executive Officer | 0 companies |
| Rebecca Georgesson | Deputy Chief Executive Officer | 0 companies |
| Andri Wilberg Orrason | Chairman | 0 companies |
| Silva Boulos Hanell | Deputy Board Member | 0 companies |
| Kristell El-Hayek | Deputy Board Member | 0 companies |